NFKB1 and hepatocellular carcinoma: By promoting the activation of the noncanonical NF-kB pathway, TRAF2 supports cell proliferation [110, 112], resistance to apoptosis in both hepatitis B virus-derived HCC and spontaneous HCC [113] and macrophage polarization toward a pro-tumoral M2 phenotype [114].